Literature DB >> 24436653

Preoperative optimization of crohn disease.

Amit Sharma1, Bertram T Chinn1.   

Abstract

Crohn disease is a chronic disease that is treated with aminosalicylates, antibiotics, and immunosuppressant agents. Most patients ultimately require surgical intervention and many will require additional surgery for recurrent disease. Consequently, surgery is generally performed only when medical management fails; however, these patients are often malnourished and immunosuppressed. Preoperative optimization is necessary to minimize morbidity, including intra-abdominal septic complications and anastomotic leaks. In this article, the authors review some considerations to improve the surgical outcome in Crohn disease.

Entities:  

Keywords:  Crohn disease; biologic therapy; immunomodulators; nutrition; steroids

Year:  2013        PMID: 24436653      PMCID: PMC3710023          DOI: 10.1055/s-0033-1348044

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  60 in total

1.  The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.

Authors:  L Marchal; G D'Haens; G Van Assche; S Vermeire; M Noman; M Ferrante; M Hiele; M Bueno De Mesquita; A D'Hoore; F Penninckx; P Rutgeerts
Journal:  Aliment Pharmacol Ther       Date:  2004-04-01       Impact factor: 8.171

2.  Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; David D Gutterman; Holger J Schuünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Outcomes of ileocolic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complications.

Authors:  Christopher Mascarenhas; Robert Nunoo; Theodor Asgeirsson; Rachelle Rivera; Don Kim; Rebecca Hoedema; Nadav Dujovny; Martin Luchtefeld; Alan T Davis; Ryan Figg
Journal:  Am J Surg       Date:  2012-03       Impact factor: 2.565

Review 4.  Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's disease.

Authors:  P Zerbib; D Koriche; S Truant; A F Bouras; G Vernier-Massouille; D Seguy; F R Pruvot; A Cortot; J F Colombel
Journal:  Aliment Pharmacol Ther       Date:  2010-05-22       Impact factor: 8.171

5.  Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn's disease.

Authors:  Alexandra Gutierrez; Hang Lee; Bruce E Sands
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

Review 6.  Nutritional status and nutritional therapy in inflammatory bowel diseases.

Authors:  Corina Hartman; Rami Eliakim; Raanan Shamir
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

7.  Preoperative total parenteral nutrition for bowel resection in Crohn's disease.

Authors:  B A Lashner; A A Evans; S B Hanauer
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

8.  Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?

Authors:  J Canedo; S-H Lee; R Pinto; S Murad-Regadas; L Rosen; S D Wexner
Journal:  Colorectal Dis       Date:  2011-11       Impact factor: 3.788

9.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

10.  Definitive risk factors for anastomotic leaks in elective open colorectal resection.

Authors:  Paul Suding; Erin Jensen; Murray A Abramson; Kamal Itani; Samuel Eric Wilson
Journal:  Arch Surg       Date:  2008-09
View more
  7 in total

1.  The effect of pre-operative optimization on post-operative outcome in Crohn's disease resections.

Authors:  Alaa El-Hussuna; Igors Iesalnieks; Nir Horesh; Sabah Hadi; Yael Dreznik; Oded Zmora
Journal:  Int J Colorectal Dis       Date:  2016-10-26       Impact factor: 2.571

Review 2.  Perioperative Considerations in Crohn Disease and Ulcerative Colitis.

Authors:  T Paul Nickerson; Amit Merchea
Journal:  Clin Colon Rectal Surg       Date:  2016-06

Review 3.  Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review.

Authors:  Marie Strøm Zangenberg; Nir Horesh; Uri Kopylov; Alaa El-Hussuna
Journal:  Int J Colorectal Dis       Date:  2017-10-19       Impact factor: 2.571

Review 4.  Preoperative Nutritional Conditioning of Crohn's Patients-Systematic Review of Current Evidence and Practice.

Authors:  Fabian Grass; Basile Pache; David Martin; Dieter Hahnloser; Nicolas Demartines; Martin Hübner
Journal:  Nutrients       Date:  2017-06-01       Impact factor: 5.717

Review 5.  Surgical Management of Small Bowel Crohn's Disease.

Authors:  Pramodh Chandrasinghe
Journal:  Front Surg       Date:  2022-04-15

Review 6.  Enteral Nutrition in Adult Crohn's Disease: Toward a Paradigm Shift.

Authors:  Simona Di Caro; Konstantinos C Fragkos; Katie Keetarut; Hui Fen Koo; Gregory Sebepos-Rogers; Hajeena Saravanapavan; John Barragry; Jennifer Rogers; Shameer J Mehta; Farooq Rahman
Journal:  Nutrients       Date:  2019-09-14       Impact factor: 5.717

Review 7.  Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease.

Authors:  Edda Russo; Francesco Giudici; Camilla Fiorindi; Ferdinando Ficari; Stefano Scaringi; Amedeo Amedei
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.